Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

IL-6 exerts central antiobesity effects in rodents

March 1, 2002

BVT-933 achieves proof of concept in phase IIa obesity trial

Feb. 28, 2002

Patients with lipodystrophy successfully treated with leptin replacement

Feb. 28, 2002

Modulators of melanin-concentrating hormone receptors discovered at Neurogen

Feb. 27, 2002

Modulators of PTPase identified under Novo Nordisk-Ontogen joint effort

Feb. 27, 2002

Squalene epoxidase inhibitor FR-194738 produces less HMG-CoA reductase induction than simvastatin

Feb. 27, 2002

Positive opinion handed down by CPMP for EVRA

Feb. 27, 2002

Acylsulfonamide compounds with hypoglycemic activity disclosed by Ajinomoto

Feb. 26, 2002

FDA approves Zometa for bone metastases from solid tumors and multiple myeloma

Feb. 26, 2002

Xanthine inhibitors of dipeptidyl-peptidase IV in development at Novo Nordisk

Feb. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...